{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:37:03Z","timestamp":1789079823671,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,3]],"date-time":"2027-03-03T00:00:00Z","timestamp":1804032000000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHS-N-260-2005-00007-C"],"award-info":[{"award-number":["HHS-N-260-2005-00007-C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.oret.2025.09.003","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:36:00Z","timestamp":1757550960000},"page":"231-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk Factors for 15-Letter Visual Acuity Loss from Geographic Atrophy Progression over 1 Year in the Age-Related Eye Disease Study 2"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8274-8609","authenticated-orcid":false,"given":"Emily","family":"Vance","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"von der Emde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0748-8371","authenticated-orcid":false,"given":"Souvick","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4108-4277","authenticated-orcid":false,"given":"Jintong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8145-9619","authenticated-orcid":false,"given":"Amitha","family":"Domalpally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Y.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Chakravarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2253-1772","authenticated-orcid":false,"given":"Tiarn\u00e1n D.L.","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2025.09.003_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjo.2025.100207","article-title":"Geographic atrophy: understanding the relationship between structure and function","volume":"14","author":"Huang","year":"2025","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.oret.2025.09.003_bib2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ophtha.2025.01.028","article-title":"Determinants of four-year visual acuity loss in geographic atrophy: an analysis of Age-Related Eye Disease Study and Age-Related Eye Disease Study 2","volume":"132","author":"Shen","year":"2025","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.09.003_bib3","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.ophtha.2018.05.028","article-title":"Progression of geographic atrophy in age-related macular degeneration: AREDS2 report number 16","volume":"125","author":"Keenan","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.09.003_bib4","first-page":"2","article-title":"Topographic variation of the growth rate of geographic atrophy in nonexudative age-related macular degeneration: a systematic review and meta-analysis","volume":"61","author":"Shen","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2025.09.003_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ophtha.2024.07.014","article-title":"Oral antioxidant and lutein\/zeaxanthin supplements slow geographic atrophy progression to the fovea in age-related macular degeneration","volume":"132","author":"Keenan","year":"2025","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.09.003_bib6","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ajo.2005.07.040","article-title":"Long-term follow-up of fixation patterns in eyes with central scotomas from geographic atrophy that is associated with age-related macular degeneration","volume":"140","author":"Sunness","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.09.003_bib7","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ophtha.2017.11.036","article-title":"Characterizing disease burden and progression of geographic atrophy secondary to age-related macular degeneration","volume":"125","author":"Chakravarthy","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.09.003_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51769-7","article-title":"Association of vision-related quality of life with visual function in age-related macular degeneration","volume":"9","author":"Pondorfer","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.oret.2025.09.003_bib9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1167\/iovs.07-1132","article-title":"Report from the NEI\/FDA ophthalmic clinical trial design and endpoints symposium","volume":"49","author":"Csaky","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2025.09.003_bib10","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1167\/iovs.17-22339","article-title":"Report from the NEI\/FDA endpoints workshop on age-related macular degeneration and inherited retinal diseases","volume":"58","author":"Csaky","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2025.09.003_bib11","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41433-024-03520-4","article-title":"Edridge Green Lecture 2022\u2014demystifying clinical trials and regulatory approvals in drug development","volume":"39","author":"Chong","year":"2025","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2025.09.003_bib12","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","article-title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials","volume":"402","author":"Heier","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.oret.2025.09.003_bib13","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","article-title":"Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial","volume":"402","author":"Khanani","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.oret.2025.09.003_bib14","author":"Anon"},{"key":"10.1016\/j.oret.2025.09.003_bib15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.oret.2025.01.006","article-title":"Assessing macular function: should we move beyond pragmatic measures of visual acuity?","volume":"9","author":"Munk","year":"2025","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2025.09.003_bib16","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.ophtha.2023.05.020","article-title":"The issue of end point discordance in dry age-related macular degeneration: how might clinical trials demonstrate a functional benefit?","volume":"130","author":"Lad","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.09.003_bib17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ophtha.2024.11.017","article-title":"Visual loss in geographic atrophy: learnings from the lampalizumab trials","volume":"132","author":"Anegondi","year":"2025","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.09.003_bib18","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.ophtha.2012.05.027","article-title":"The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1)","volume":"119","author":"AREDS2 Research Group","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.09.003_bib19","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1167\/iovs.13-11804","article-title":"Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2)","volume":"54","author":"Danis","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2025.09.003_bib20","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.ophtha.2016.06.025","article-title":"Evaluation of geographic atrophy from color photographs and fundus autofluorescence images: Age-Related Eye Disease Study 2 report number 11","volume":"123","author":"Domalpally","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.09.003_bib21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ophtha.2023.09.013","article-title":"Critical dependence on area in relationship between ARMS2\/HTRA1 genotype and faster geographic atrophy enlargement: Age-Related Eye Disease Study 2 report number 33","volume":"131","author":"Agr\u00f3n","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.09.003_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ajo.2025.03.021","article-title":"Phase 2 study of the anti-high temperature requirement A1 (HtrA1) fab galegenimab (FHTR2163) in geographic atrophy secondary to age-related macular degeneration","volume":"275","author":"Eichenbaum","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.09.003_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.oret.2022.08.022","article-title":"Treating geographic atrophy\u2014are we ready? A call to image","volume":"7","author":"Guymer","year":"2023","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2025.09.003_bib24","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.oret.2020.01.019","article-title":"Visual function decline resulting from geographic atrophy: results from the Chroma and Spectri Phase 3 trials","volume":"4","author":"Heier","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2025.09.003_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55484-1","article-title":"Associations with photoreceptor thickness measures in the UK Biobank","volume":"9","author":"Chua","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.oret.2025.09.003_bib26","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.oret.2022.03.022","article-title":"Adherence to a Mediterranean diet and geographic atrophy enlargement rate: Age-Related Eye Disease Study 2 report 29","volume":"6","author":"Agr\u00f3n","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2025.09.003_bib27","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/nu17050771","article-title":"Relationships between diet and geographic atrophy progression in the Age-Related Eye Diseases Studies 1 and 2","volume":"17","author":"Agr\u00f3n","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.oret.2025.09.003_bib28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/jamaophthalmol.2019.1318","article-title":"Assessment of novel genome-wide significant gene loci and lesion growth in geographic atrophy secondary to age-related macular degeneration","volume":"137","author":"Grassmann","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.09.003_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126636","article-title":"Clinical and genetic factors associated with progression of geographic atrophy lesions in age-related macular degeneration","volume":"10","author":"Grassmann","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.oret.2025.09.003_bib30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ophtha.2017.08.038","article-title":"The progression of geographic atrophy secondary to age-related macular degeneration","volume":"125","author":"Fleckenstein","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.09.003_bib31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/IAE.0000000000002337","article-title":"Mesopic and dark-adapted two-color fundus-controlled perimetry in geographic atrophy secondary to age-related macular degeneration","volume":"40","author":"Pfau","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.09.003_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100879","article-title":"Variation in mesopic retinal sensitivity relative to distance from geographic atrophy in age-related macular degeneration","volume":"5","author":"Mukherjee","year":"2025","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.oret.2025.09.003_bib33","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/jamaophthalmol.2020.2914","article-title":"Progression of photoreceptor degeneration in geographic atrophy secondary to age-related macular degeneration","volume":"138","author":"Pfau","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.09.003_bib34","article-title":"Neuroprotection for age-related macular degeneration","volume":"2","author":"Lin","year":"2022","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.oret.2025.09.003_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100318","article-title":"Progression of geographic atrophy: retrospective analysis of patients from the IRIS\u00ae Registry (Intelligent Research in Sight)","volume":"3","author":"Rahimy","year":"2023","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.oret.2025.09.003_bib36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ophtha.2015.09.036","article-title":"Natural history of geographic atrophy progression secondary to age-related macular degeneration (Geographic Atrophy Progression Study)","volume":"123","author":"Schmitz-Valckenberg","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.09.003_bib37","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamaophthalmol.2018.1544","article-title":"Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and Spectri Phase 3 randomized clinical trials","volume":"136","author":"Holz","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.09.003_bib38","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2020.08.027","article-title":"C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2\/3 trial","volume":"128","author":"Jaffe","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.09.003_bib39","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1097\/IAE.0b013e3182509778","article-title":"Comparison of color fundus photographs and fundus autofluorescence images in measuring geographic atrophy area","volume":"32","author":"Khanifar","year":"2012","journal-title":"Retina"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025004129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025004129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:46:19Z","timestamp":1773920779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653025004129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2468653025004129"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2025.09.003","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors for 15-Letter Visual Acuity Loss from Geographic Atrophy Progression over 1 Year in the Age-Related Eye Disease Study 2","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2025.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}